Augmentation of macular pigment following supplementation with all three macular carotenoids : An exploratory study

Connolly, Eithne E. and Beatty, Stephen and Thurnham, David I. and Loughman, James and Howard, Alan N. and Stack, Jim and Nolan, John M. (2010) Augmentation of macular pigment following supplementation with all three macular carotenoids : An exploratory study. Current Eye Research, 35 (4). pp. 335-351. ISSN 0271-3683

Full text not available from this repository. (Request a copy)


Purpose:At the macula, the carotenoids meso-zeaxanthin (MZ), lutein (L), and zeaxanthin (Z) are collectively referred to as macular pigment (MP). This study was designed to measure serum and macular responses to a macular carotenoid formulation. Materials and Methods:Ten subjects were recruited into this study (five normal and five with early age-related macular degeneration [AMD]). Subjects were instructed to consume a formulation containing 7.3mg of MZ, 3.7mg of L, and 0.8mg of Z everyday over an eight-week period. The spatial profile of MP optical density (i.e., MPOD at 0.25°, 0.5°, 1°, and 1.75°) was measured using customized heterochromatic flicker photometry, and a blood sample was collected at each study visit in order to analyze serum concentrations of MZ, L, and Z. Results:There was a significant increase in serum concentrations of MZ and L after two weeks of supplementation (p<0.05). Baseline serum carotenoid analysis detected a small peak eluting at the same time as MZ in all subjects, with a mean ± SD of 0.02±0.01 μmol/L. We report significant increases in MPOD at 0.25°, 0.5°, 1°, and average MPOD across its spatial profile after just two weeks of supplementation (p<0.05, for all). Four subjects (one normal and three AMD) who had an atypical MPOD spatial profile (i.e., central dip) at baseline had the more typical MPOD spatial profile (i.e., highest MPOD at the center) after eight weeks of supplementation. Conclusion:We report significant increases in serum concentrations of MZ and L following supplementation with MZ, L, and Z and a significant increase in MPOD, including its spatial profile, after two weeks of supplementation. Also, this study has detected the possible presence of MZ in human serum pre-supplementation and the ability of the study carotenoid formulation to rebuild central MPOD in subjects who have atypical profiles at baseline.

Item Type: Article
Additional Information: Funding Information: This study was supported by a grant from The Howard Foundation, Cambridge, CB22 5LA, United Kingdom. We thank Mr. Jonathon Oates, Head of Pharmacy, Waterford Regional Hospital, Dunmore Road, Waterford, Ireland, for his help in labeling and packaging the study capsules. Alan N. Howard is a trustee of the Howard Foundation, UK charity number 285822, and as such receives no remuneration from the Foundation. David I. Thurnham is a consultant to the Howard Foundation and receives consulting fees.
Uncontrolled Keywords: /dk/atira/pure/subjectarea/asjc/2700/2731
Departments or Groups:
Depositing User: Admin SSL
Date Deposited: 19 Oct 2022 23:10
Last Modified: 30 Jul 2023 22:25

Actions (login required)

View Item View Item